2014
DOI: 10.4172/1948-5956.1000286
|View full text |Cite
|
Sign up to set email alerts
|

Polycarbonate Micelles for Cancer Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2016
2016
2017
2017

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…[21][22][23][24][25] In this case, the APCs can play the role of hydrophobic (HPO) core-forming blocks for drug delivery of micellar nanocarriers. [26][27][28][29][30] In drug delivery systems, in order to control the in vivo drug release rate with a prolonged…”
Section: Doi: 101002/mame201700042mentioning
confidence: 99%
See 1 more Smart Citation
“…[21][22][23][24][25] In this case, the APCs can play the role of hydrophobic (HPO) core-forming blocks for drug delivery of micellar nanocarriers. [26][27][28][29][30] In drug delivery systems, in order to control the in vivo drug release rate with a prolonged…”
Section: Doi: 101002/mame201700042mentioning
confidence: 99%
“…APCs can also be used for the preparation of modern nanostructures like polymeric micelles that carry drugs through the bloodstream and deliver them to the desired locations in order to act within tumors . In this case, the APCs can play the role of hydrophobic (HPO) core‐forming blocks for drug delivery of micellar nanocarriers . In drug delivery systems, in order to control the in vivo drug release rate with a prolonged circulation time, scientists have suggested polymeric micelle based APC block copolymers (BCPs) .…”
Section: Introductionmentioning
confidence: 99%